ADC Therapeutics S.A. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
REDMILE GROUP, LLC | 05/15/2025 | 15.67 M | $22.09 M | 0.00% | 14.61% |
PROSIGHT MANAGEMENT, LP | 05/15/2025 | 9.54 M | $13.46 M | 0.29% | 8.90% |
ORBIMED ADVISORS LLC | 05/15/2025 | 5.97 M | $8.42 M | 0.00% | 5.57% |
BLACKROCK, INC. | 05/02/2025 | 4.91 M | $6.93 M | -1.96% | 4.58% |
MORGAN STANLEY | 05/15/2025 | 3.02 M | $4.26 M | -23.67% | 2.82% |
PLATINUM INVESTMENT MANAGEMENT LTD | 05/15/2025 | 2.04 M | $2.87 M | 26.39% | 1.90% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.80 M | $2.54 M | 39.49% | 1.68% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 1.58 M | $2.23 M | -5.38% | 1.48% |
STATE STREET CORP | 05/15/2025 | 1.21 M | $1.71 M | 1.95% | 1.13% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 969.75 K | $1.37 M | 0.69% | 0.90% |
WOODLINE PARTNERS LP | 05/15/2025 | 815.53 K | $1.15 M | -57.83% | 0.76% |
UBS GROUP AG | 05/13/2025 | 767.06 K | $1.08 M | -13.28% | 0.72% |
BLUE OWL CAPITAL HOLDINGS LP | 05/15/2025 | 733.57 K | $1.03 M | 0.00% | 0.68% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 692.08 K | $975.83 K | -3.43% | 0.65% |
VANGUARD GROUP INC | 05/09/2025 | 652.01 K | $919.33 K | 1.15% | 0.61% |
NORTHERN TRUST CORP | 05/13/2025 | 496.14 K | $699.56 K | 4.19% | 0.46% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 224.08 K | $315.95 K | 0.00% | 0.21% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 201.17 K | $283.65 K | 411.08% | 0.19% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 194.26 K | $273.90 K | 0.00% | 0.18% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 164.82 K | $232.39 K | -59.91% | 0.15% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 159.47 K | $224.85 K | -7.28% | 0.15% |
05/12/2025 | 152.05 K | $214.39 K | 100.00% | 0.14% | |
FMR LLC | 05/12/2025 | 136.42 K | $192.35 K | 7.40% | 0.13% |
INVESCO LTD. | 05/12/2025 | 132.70 K | $187.11 K | 286.12% | 0.12% |
SANIBEL CAPTIVA TRUST COMPANY, INC. | 04/15/2025 | 113.00 K | $159.33 K | 0.00% | 0.11% |
RHUMBLINE ADVISERS | 05/29/2025 | 111.63 K | $157.39 K | 1.45% | 0.10% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 103.78 K | $146.33 K | 102.70% | 0.10% |
BARCLAYS PLC | 05/15/2025 | 101.03 K | $142.00 K | -28.60% | 0.09% |
BRYN MAWR TRUST CO | 05/08/2025 | 100.00 K | $141.00 K | 0.00% | 0.09% |
SQUAREPOINT OPS LLC | 05/15/2025 | 91.87 K | $129.54 K | -14.32% | 0.09% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 67.78 K | $95.57 K | 62.02% | 0.06% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 62.87 K | $88.65 K | 63.58% | 0.06% |
CITIGROUP INC | 05/12/2025 | 57.65 K | $81.28 K | -10.12% | 0.05% |
DEUTSCHE BANK AG\ | 05/09/2025 | 56.06 K | $79.05 K | 0.00% | 0.05% |
MAGNETAR FINANCIAL LLC | 05/15/2025 | 55.76 K | $78.62 K | 0.00% | 0.05% |
PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 54.19 K | $76.40 K | 100.00% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 48.56 K | $68.47 K | 4.39% | 0.05% |
METLIFE INVESTMENT MANAGEMENT, LLC | 05/14/2025 | 45.49 K | $64.14 K | 46.18% | 0.04% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 44.69 K | $63.01 K | -75.61% | 0.04% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 39.84 K | $56.17 K | -1.46% | 0.04% |
JPMORGAN CHASE & CO | 05/12/2025 | 39.72 K | $56.00 K | 7.29% | 0.04% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 39.69 K | $55.96 K | 136.32% | 0.04% |
COMMONWEALTH EQUITY SERVICES, LLC | 05/09/2025 | 39.31 K | $55.00 K | -0.76% | 0.04% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 36.21 K | $52.00 K | 25.60% | 0.03% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 29.70 K | $41.87 K | 3.87% | 0.03% |
DLK INVESTMENT MANAGEMENT, LLC | 04/23/2025 | 26.81 K | $37.80 K | 3.88% | 0.03% |
LPL FINANCIAL LLC | 05/07/2025 | 25.00 K | $35.25 K | 0.00% | 0.02% |
SG AMERICAS SECURITIES, LLC | 04/15/2025 | 23.88 K | $34.00 K | -33.93% | 0.02% |
SEI INVESTMENTS CO | 05/14/2025 | 22.99 K | $32.41 K | 0.00% | 0.02% |
IEQ CAPITAL, LLC | 05/14/2025 | 22.93 K | $32.32 K | 100.00% | 0.02% |
ADC Therapeutics S.A. institutional Ownership - FAQ's
During the previous two years, 96 institutional investors and hedge funds held shares of ADC Therapeutics S.A.. The most heavily invested institutionals were:
Redmile Group, LLC: 15.67 M
Prosight Management, LP: 9.54 M
ORBIMED ADVISORS LLC: 5.97 M
BlackRock, Inc.: 4.91 M
MORGAN STANLEY: 3.02 M
PLATINUM INVESTMENT MANAGEMENT LTD: 2.04 M
50.37% of ADC Therapeutics S.A. stock is owned by institutional investors.
Institutional investors have bought a total of 60.40 M shares in the last 24 months. This purchase volume represents approximately $190.25 M in transactions.